Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022008095
Abstract: Key Points • Belumosudil is associated with clinical responses in BOS, particularly in less advanced disease.• No significant correlation was identified between FEV1 evaluations and measures of symptoms in predominantly mild or moderate disease. read more here.
Keywords: clinical response; response belumosudil; syndrome combined; belumosudil bronchiolitis ... See more keywords